Roberto Scarpioni
About
In The Last Decade
Roberto Scarpioni
24 papers receiving 440 citations
Peers
Comparison fields: 5 of 81
- Nephrology 135
- Molecular Biology 125
- Pulmonary and Respiratory Medicine 115
- Surgery 114
- Infectious Diseases 49
Countries citing papers authored by Roberto Scarpioni
This map shows the geographic impact of Roberto Scarpioni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Scarpioni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Scarpioni more than expected).
Fields of papers citing papers by Roberto Scarpioni
This network shows the impact of papers produced by Roberto Scarpioni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Scarpioni. The network helps show where Roberto Scarpioni may publish in the future.
Co-authorship network of co-authors of Roberto Scarpioni
This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Scarpioni. A scholar is included among the top collaborators of Roberto Scarpioni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Scarpioni. Roberto Scarpioni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 8 | |
| 3 | 3 | |
| 4 | 4 | |
| 5 | 11 | |
| 6 | Covid-19 and its impact on nephropathic patients: the experience at Ospedale "Guglielmo da Saliceto" in Piacenza. | 40 |
| 7 | 9 | |
| 8 | 5 | |
| 9 | 88 | |
| 10 | 45 | |
| 11 | 6 | |
| 12 | 12 | |
| 13 | 28 | |
| 14 | 26 | |
| 15 | 68 | |
| 16 | 19 | |
| 17 | 0 | |
| 18 | Atherosclerotic renovascular disease: medical therapy versus medical therapy plus renal artery stenting in preventing renal failure progression: the rationale and study design of a prospective, multicenter and randomized trial (NITER). | 29 |
| 19 | 3 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.